safety of glp 1 drugs GLP-1 have taken the world by storm, helping many people lose 11%–16% their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't GLP-1 Monitoring for Safe

safety of glp 1 drugs GLP-1 have taken the world by storm, helping many people lose 11%–16% their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't GLP-1 Monitoring for Safe

GLP-1 Monitoring for Safe and Effective Use | Forefront Dermatology

for weight management

✔️ Approval for Diabetes and Weight Management Over the past decade, three GLP-1/GIP receptor agonists— liraglutide, semaglutide, and tirzepatide —initially approved by the FDA for adults with type 2 diabetes, have also gained FDA approval for chronic weight management in people without diabetes, provided they meet specific criteria: a BMI of ≥30, or ≥27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes